Is chemoimmunotherapy a game changer in the treatment of locally advanced head and neck squamous cell carcinoma?

Abstract Pembrolizumab and chemotherapy (chemoimmunotherapy) were administered to 2 head and neck squamous cell carcinoma (HNSCC) patients with extremely advanced local tumors and distant metastases with palliative intent. However, they demonstrated strikingly good responses and achieved remission....

Full description

Bibliographic Details
Main Authors: Muneyuki Masuda, Ryozaburo Nagata, Hirotaka Hara, Keiji Kuroki, Kuniaki Sato, Fumihide Rikimaru, Satoshi Toh, Yuichiro Higaki
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.4793